Supplementary Table 1

Published: 20 January 2025| Version 1 | DOI: 10.17632/5tj8phdkj8.1
Contributor:
Joyce Kang

Description

Supplementary Table 1 for Kang & Nabel Smith et al. (JAAD, 2025). "Infection risk of rituximab monotherapy versus combination therapy with rituximab and mycophenolic acid in systemic sclerosis"

Files

Institutions

  • Brigham and Women's Hospital
  • Harvard Medical School
  • Massachusetts General Hospital

Categories

Dermatology, Rituximab, Systemic Sclerosis

Licence